Concept explainers
(a)
Ethics Case
The Research and Development (R&D) division of Corporation P developed a disinfectant chemical for killer bees that are attacking the Country M and the southern part of Country U. Since the president’s job is at stake due to decreasing sales and profits for the past couple of years, he is anxious to sell the chemical in the market.
However, the director of the R & D division is not in favor of the president’s decision. He strongly recommends to first test the chemical in the lab to know the side effects on other living beings. On the other hand, the president is not ready to wait any more for the lab test. He convinces the director and establishes a separately owned corporation to protect the corporation and the losses from any law suits if the chemical turned out be a disaster. Thus, the corporation invests the patent amount of $10 for the chemical in the new corporation.
To state: the stakeholders in the situation.
(b)
To explain: whether the president’s motives and actions are ethical.
(c)
To explain: whether the Corporation P could shield itself against the losses of Corporation C.
Want to see the full answer?
Check out a sample textbook solutionChapter 11 Solutions
FIN. ACCT.-TOOLS FOR BUS.DEC.MAKING-CODE
- Bluefin tuna is very popular; however, its supply is being reduced through global overfishing and pollution. Therefore U.S. placed it on its watch list. Their observations indicated that many fisherman currently fish more than the legal quota. This excess overfishing may require official protection if unable to police fishing and preserve habitats. Based on Bluefin tuna case answer the following three questions: Why is the price of Bluefin tuna skyrocketing? Explain your answer Why might the U.S. be reluctant to place the Bluefin tuna on the endangered species list? Explain your answer What are some of the consequences of acting too slowly or too quickly in their assessment? Explain your answerarrow_forwardAsiaChem is a pharmaceutical company in Asia. The company’s research department has identified a compound that can cure a common cold without any side effects. Unfortunately, the manufacture of this compound requires the company to invest heavily in a high technology factory which will use a number of new techniques, some of which are unproven. The company will also need to recruit and retain the services of a number of eminent scientists, each of whom is both vital to the project and would be irreplaceable. Financing this project will require the company to borrow heavily. The company is unlikely to survive as an independent entity if it invests in this project and it fails. The directors have been advised that there is at least a 50% chance of a catastrophic failure. The project has a beta of 0.5. The risk free rate is 3% and the equity risk premium is 8%. The project offers an estimated return of 24%. Required: I. Calculate the required rate of return for the project. II.…arrow_forwardRachel Duncan is the CEO of Dyad Pharmaceuticals, and she faces a decision about her company's newest and most promising drug candidate: NZT-48. Clinical trials have been completed, and the team awaits an approval decision from the U.S. Food and Drug Administration (FDA) before it can be marketed. In the meantime, Ms. Duncan receives an offer from a global biotech company, International Genetics Incorporated (InGen) to license NZT-48 from Dyad. (Licensing here means that InGen provides capital to help the development and launch process of the new drug, but will share the profits with Dyad once the drug enters the market.) With InGen's offer, Ms. Duncan has a decision to make right now, before the FDA's decision. She can accept InGen's offer. If FDA approves the new drug, then Ms. Duncan estimates that her company's valuation will reach $3 billion; if FDA does not approve, with InGen's injected capital, Ms. Duncan estimates that her company would still value at $1 billion. If Ms. Duncan…arrow_forward
- Following the outbreak of the Novel Coronavirus (COVID 19), CPC a pharmaceutical company is considering introducing a new vaccine unto the market to help fight the virus. This will require the injection of huge capital to the tune of GH¢40,000,000 for the purchase of the equipment for production. It will cost CPC an additional GH¢ 5,500,000 to set up the production facility and install that equipment for production. Mr. Smart, the CEO of CPC believes that the vaccine could be manufactured in a building owned by the firm and located in East Legon. This vacant building and the land can be sold for GH¢ 1,500,000 after taxes. CPC will finance the production of the vaccine (including initial working capitalinvestment) by issuing 2000,000 new common stocks at GH¢ 20 per share from its existing shareholders. A total of GH¢ 15,000,000 is expected to be raised from the rights issue. It expects to finance the remaining from the issue of a 5-year bondwith a before-tax yield to…arrow_forwardFollowing the outbreak of the Novel Coronavirus (COVID 19), CPC a pharmaceutical company is considering introducing a new vaccine unto the market to help fight the virus. This will require the injection of huge capital to the tune of GH¢40,000,000 for the purchase of the equipment for production. It will cost CPC an additional GH¢ 5,500,000 to set up the production facility and install that equipment for production. Mr. Smart, the CEO of CPC believes that the vaccine could be manufactured in a building owned by the firm and located in East Legon. This vacant building and the land can be sold for GH¢ 1,500,000 after taxes. CPC will finance the production of the vaccine (including initial working capital investment) by issuing 2000,000 new common stocks at GH¢ 20 per share from its existing shareholders. A total of GH¢ 15,000,000 is expected to be raised from the rights issue. It expects to finance the remaining from the issue of a 5-year bond with a before-tax yield to maturity (YTM)…arrow_forwardFollowing the outbreak of the Novel Coronavirus (COVID 19), CPC a pharmaceutical company is considering introducing a new vaccine unto the market to help fight the virus. This will require the injection of huge capital to the tune of GH¢40,000,000 for the purchase of the equipment for production. It will cost CPC an additional GH¢ 5,500,000 to set up the production facility and install that equipment for production. Mr. Smart, the CEO of CPC believes that the vaccine could be manufactured in a building owned by the firm and located in East Legon. This vacant building and the land can be sold for GH¢ 1,500,000 after taxes. CPC will finance the production of the vaccine (including initial working capital investment) by issuing 2000,000 new common stocks at GH¢ 20 per share from its existing shareholders. A total of GH¢ 40,000,000 is expected to be raised from the rights issue. It expects to finance the remaining investment including initial working capital investment from the issue of a…arrow_forward
- Following the outbreak of the Novel Coronavirus (COVID 19), CPC a pharmaceutical company is considering introducing a new vaccine unto the market to help fight the virus. This will require the injection of huge capital to the tune of GH¢40,000,000 for the purchase of the equipment for production. It will cost CPC an additional GH¢ 5,500,000 to set up the production facility and install that equipment for production. Mr. Smart, the CEO of CPC believes that the vaccine could be manufactured in a building owned by the firm and located in East Legon. This vacant building and the land can be sold for GH¢ 1,500,000 after taxes. CPC will finance the production of the vaccine (including initial working capital investment) by issuing 2000,000 new common stocks at GH¢ 20 per share from its existing shareholders. A total of GH¢ 15,000,000 is expected to be raised from the rights issue. It expects to finance the remaining from the issue of a 5-year bond with a before-tax yield to maturity (YTM)…arrow_forwardThe following quote appeared in an article entitled ‘Business and society in the coming decades’, which was available on the website of McKinsey & Company (accessed in October 2015). “There are compelling reasons companies should seize the initiative to drive social and business benefits. First, in an interconnected world facing unprecedented environmental and social challenges, society will demand it. Increasingly, a basic expectation among customers, governments, and communities will be that the companies they do business with provide a significant net positive return for society at large, not just for investors. This will be part of the implicit contract or license to operate”. Now a) Explain the above statement in the context of corporate social responsibility. b) Further, do you think such a statement would impact the perceived ‘legitimacy’ of companies? Explain.arrow_forwardTommy Gunn is a division manager for K-Cern Inc., a small pharmaceutical company. Tommy's division has been working on a new drug that has the potential to revolutionize the treatment of skin cancer. Once the drug is proven to be effective in clinical trials, it will be approved for sale by the government and patented by the company. Because of the potential market for this drug, it is highly likely that the company's revenues and net income will increase significantly when it is approved. Tommy recently saw an internal company memo indicating that the drug passed its final clinical trial and that the company has received government approval to sell the drug. The company will issue a press release announcing this news in the next two days, and this announcement is expected to result in a dramatic increase in the company's stock price. Tommy knows that there is “free money” to be made if he invests in the stock before the announcement is made. However, K-Cern has a strict policy against…arrow_forward
- Tommy Gunn is a division manager for K-Cern Inc., a small pharmaceutical company. Tommy's division has been working on a new drug that has the potential to revolutionize the treatment of skin cancer. Once the drug is proven to be effective in clinical trials, it will be approved for sale by the government and patented by the company. Because of the potential market for this drug, it is highly likely that the company's revenues and net income will increase significantly when it is approved. Tommy recently saw an internal company memo indicating that the drug passed its final clinical trial and that the company has received government approval to sell the drug. The company will issue a press release announcing this news in the next two days, and this announcement is expected to result in a dramatic increase in the company's stock price. Tommy knows that there is “free money” to be made if he invests in the stock before the announcement is made. However, K-Cern has a strict policy against…arrow_forwardFomguard LLC of South Korea developed a hightech fiber-optic fencing mesh (FOM) that contains embedded sensors that can differentiate between human and animal contact. In an effort to curtail illegal entry into the United States, a FOM fence has been proposed for some sections of the U.S. border with Canada. The cost for erecting the fence in year 1 is expected to be $7 million, decreasing by $500,000 each year through year 5. At an interest rate of 10% per year, what is the equivalent uniform annual cost of the fence for years 1 to 5?arrow_forward